Zacks Research Expects Weaker Earnings for Quest Diagnostics
Quest Diagnostics Incorporated (NYSE:DGX – Free Report) – Analysts at Zacks Research decreased their Q3 2025 earnings per share (EPS) estimates for Quest Diagnostics in a research report issued on Wednesday, May 21st. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings of $2.50 per share for the quarter, […]
